Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net income	$ 112,776,000	$ 15,415,000	$ 8,722,000
Deferred income taxes	6,560,000	(31,828,000)	(1,189,000)
Depreciation and amortization	203,127,000	320,000,000	303,484,000
Loss on extinguishment of debt	0	0	1,187,000
Stock-based compensation (net of amounts capitalized)	63,457,000	57,455,000	43,732,000
Amortization of deferred financing fees	2,523,000	3,739,000	4,602,000
(Gain) loss on equity method investments	(15,251,000)	6,089,000	1,496,000
All other items, net	715,000	732,000	638,000
Accounts receivable	(6,366,000)	(9,538,000)	(18,712,000)
Inventory	9,822,000	(50,958,000)	(10,183,000)
Prepaid expenses and other current assets	(2,985,000)	(1,153,000)	(4,227,000)
Other assets	5,543,000	3,019,000	3,441,000
Accounts payable	(18,808,000)	2,759,000	4,730,000
Accrued expenses and other current liabilities	9,790,000	4,899,000	5,929,000
Deferred revenue	6,845,000	(2,961,000)	4,871,000
Other long-term liabilities	(1,793,000)	(2,756,000)	(3,792,000)
Net cash provided by operating activities	375,955,000	314,913,000	344,729,000
Cash flows from investing activities:
Capital expenditures	(69,890,000)	(73,487,000)	(71,267,000)
Investment in related parties	0	10,000,000	50,000,000
Investment in related parties	(110,713,000)	0	0
Net cash used in investing activities	(180,603,000)	(83,487,000)	(121,267,000)
Cash flows from financing activities:
Borrowings under the Term Loan	419,783,000	63,940,000	0
Payments on the Term Loan	(114,194,000)	(72,315,000)	(116,500,000)
Repurchases of common stock	(407,725,000)	(247,019,000)	(257,059,000)
Payment of deferred financing fees	(345,000)	(1,162,000)	0
Proceeds from exercise of stock options	3,441,000	3,958,000	3,872,000
Tax payments upon settlement of stock awards	(6,702,000)	(9,680,000)	(5,293,000)
Payment of common stock dividends	(64,739,000)	(64,774,000)	0
Net cash used in financing activities	(170,481,000)	(327,052,000)	(374,980,000)
Effect of exchange rate changes on cash and cash equivalents	(3,215,000)	(1,274,000)	(625,000)
Net increase (decrease) in cash and cash equivalents and restricted cash	21,656,000	(96,900,000)	(152,143,000)
Cash, cash equivalents and restricted cash, beginning of period	71,870,000	168,770,000	320,913,000
Cash, cash equivalents and restricted cash, end of period	93,526,000	71,870,000	168,770,000
Supplemental cash flow information:
Interest paid, net of amounts capitalized	95,311,000	91,936,000	63,880,000
Income taxes paid, net	5,248,000	4,225,000	2,224,000
Supplemental disclosure of non-cash investing and financing activities:
Property and equipment received but not paid for yet	13,169,000	7,070,000	5,697,000
Capitalized stock-based compensation	4,870,000	6,684,000	4,635,000
Dividends accrued on common stock	$ 2,535,000	$ 1,315,000	$ 16,616,000